Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1981-9-25
|
pubmed:abstractText |
Plasma cortisol, 17-hydroxyprogesterone (17-OH-P), progesterone, FSH, LH and prolactin were determined by RIA, in 14 cancer patients without metastases aged between 40 and 74 years (6 cases of breast cancer: T123, N01, M0 and 8 with other forms of cancer). The cancer patients were investigated: (A) under basal conditions, (B) after three days' adrenal suppression by dexamethasone, 3 mg/day and (C) immediately after local radiation therapy (4500 rads). The basal mean hormonal values in these patients showed increased cortisol, decrease 17-OH-P and normal values of progesterone, FSH, LH and prolactin. Plasma cortisol was significantly reduced by adrenal suppression with a percentage reduction of 19.44 without differences between breast cancer patients and patients with other forms of cancer; adrenal suppression induced an increase of 17-OH-P only in male cancer patients. The only significant hormonal changes after local radiation therapy were increased plasma 17-OH-P values in both female and male cancer patients. A second group investigated in the present study consisted of 11 patients (6 castrated and 5 postmenopausal women) with metastatic breast cancer and presented increased plasma cortisol values, decreased 17-OH-P values, and a great scatter in the estrone values, some of them being very high.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone,
http://linkedlifedata.com/resource/pubmed/chemical/Follicle Stimulating Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrocortisone,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyprogesterones,
http://linkedlifedata.com/resource/pubmed/chemical/Luteinizing Hormone,
http://linkedlifedata.com/resource/pubmed/chemical/Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Prolactin
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0253-1801
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
115-21
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6789444-Adrenal Glands,
pubmed-meshheading:6789444-Adult,
pubmed-meshheading:6789444-Aged,
pubmed-meshheading:6789444-Breast Neoplasms,
pubmed-meshheading:6789444-Dexamethasone,
pubmed-meshheading:6789444-Female,
pubmed-meshheading:6789444-Follicle Stimulating Hormone,
pubmed-meshheading:6789444-Humans,
pubmed-meshheading:6789444-Hydrocortisone,
pubmed-meshheading:6789444-Hydroxyprogesterones,
pubmed-meshheading:6789444-Luteinizing Hormone,
pubmed-meshheading:6789444-Male,
pubmed-meshheading:6789444-Middle Aged,
pubmed-meshheading:6789444-Neoplasm Metastasis,
pubmed-meshheading:6789444-Progesterone,
pubmed-meshheading:6789444-Prolactin
|
pubmed:articleTitle |
Adrenal function in early and metastatic breast cancer: dexamethasone suppression of plasma cortisol.
|
pubmed:publicationType |
Journal Article
|